Shanghai Pharmaceuticals' MediTrust Health Files for IPO in Hong Kong Amidst AI-Powered Healthcare Payment Transformation
CompanyDeals

Shanghai Pharmaceuticals’ MediTrust Health Files for IPO in Hong Kong Amidst AI-Powered Healthcare Payment Transformation

Hisun Pharmaceuticals Receives NMPA Approval for HS387 Clinical Trials in Advanced Solid Tumors
CompanyDrug

Hisun Pharmaceuticals Receives NMPA Approval for HS387 Clinical Trials in Advanced Solid Tumors

China Isotope & Radiation Corporation Showcases C-14 Barium Carbonate at International Symposium
CompanyMedical Device

China Isotope & Radiation Corporation Showcases C-14 Barium Carbonate at International Symposium

Merck KGaA Completes $3.4 Billion Acquisition of SpringWorks Therapeutics Boosting Rare Oncology Portfolio
CompanyDeals

Merck KGaA Completes $3.4 Billion Acquisition of SpringWorks Therapeutics Boosting Rare Oncology Portfolio

Allergan Aesthetics' SKINVIVE by JUVÉDERM Accepted for FDA Review to Reduce Neck Lines
CompanyDrug

Allergan Aesthetics’ SKINVIVE by JUVÉDERM Accepted for FDA Review to Reduce Neck Lines

Hybio and iCarbonX Enter CRDMO Service Pact and Strategic Investment to Advance Peptide Drug Pipeline
CompanyDeals

Hybio and iCarbonX Enter CRDMO Service Pact and Strategic Investment to Advance Peptide Drug Pipeline

EnChannel Medical Acquires AcQMap Platform Assets from Acutus Medical to Strengthen Non-Contact Mapping Tech
CompanyDeals

EnChannel Medical Acquires AcQMap Platform Assets from Acutus Medical to Strengthen Non-Contact Mapping Tech

Jiangsu Hengrui Pharmaceuticals Partners with NSFC to Establish Private Enterprise Innovation Fund
CompanyDeals

Jiangsu Hengrui Pharmaceuticals Partners with NSFC to Establish Private Enterprise Innovation Fund

Sanofi Invests $25 Million in China's Adagene to Advance SAFEbody Program
CompanyDeals

Sanofi Invests $25 Million in China’s Adagene to Advance SAFEbody Program

NHSA Unveils Plans for 2025 National Drug List Adjustments and Commercial Insurance Drug List
Policy / Regulatory

NHSA Unveils Plans for 2025 National Drug List Adjustments and Commercial Insurance Drug List

Esteve to Acquire Sanofi's Caprelsa Rights in Over 50 Countries for Medullary Thyroid Cancer Treatment
CompanyDeals

Esteve to Acquire Sanofi’s Caprelsa Rights in Over 50 Countries for Medullary Thyroid Cancer Treatment

AbbVie to Acquire Capstan Therapeutics for Its First-in-Class CAR-T Candidate
CompanyDeals

AbbVie to Acquire Capstan Therapeutics for Its First-in-Class CAR-T Candidate